The global market for transplant diagnostics is projected to grow significantly, reaching an estimated US$ 1,542.89 million by 2027, up from US$ 789.88 million in 2018. This growth represents a compound annual growth rate (CAGR) of 7.9% from 2019 to 2027.
Several factors are propelling the expansion of the transplant diagnostics market. These include the increasing incidence of cardiovascular diseases, robust advancements in the biotechnology sector, a heightened demand for organ transplants, and a surge in cell-based research initiatives. Nevertheless, challenges such as the high costs associated with organ transplant surgeries and a limited supply of organ donors may hinder market growth to some degree.
The rise in chronic illnesses that impair the functioning of vital organs such as the heart, lungs, liver, and kidneys is contributing to a growing need for organ transplants. The frequency of organ transplant procedures is on the rise globally. For example, in Spain, around 5,260 transplant operations were conducted, with approximately 3,200 being kidney transplants and about 1,200 liver transplants. Additionally, there were roughly 300 heart transplants and nearly 360 lung transplants performed. The collaboration between public and private sectors, along with the efforts of transplant coordinators, has significantly enhanced the landscape of organ transplantation. Both developing and developed nations are witnessing an increase in transplant surgeries. Countries like India and Singapore are emerging as prominent medical tourism hubs in the Asia-Pacific region, offering advanced medical treatments and services.
The global transplant diagnostics market is categorized into various segments, including product and services, type, technology, application, and end user. The product and services segment encompasses instruments, reagents and consumables, as well as software and services. In terms of type, the market is divided into solid organ transplantation, soft tissue transplantation, and stem cell transplantation. The technology segment is classified into molecular assays and non-molecular assays. Furthermore, the application segment is divided into diagnostic applications and research applications. Lastly, the end user segment includes hospitals and transplant centers, research laboratories and academic institutions, as well as independent reference laboratories.
Key sources of information for the transplant diagnostics market report include reputable organizations such as the World Health Organization, the Dubai Health Authority, the Australian Bone Marrow Donor Registry, the Canadian Institute of Health Information, the National Organ Donation and Transplantation Committee, and the Canadian Society of Transplantation, among others.